Veronica Mason

719 total citations
7 papers, 570 citations indexed

About

Veronica Mason is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Veronica Mason has authored 7 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Veronica Mason's work include Kruppel-like factors research (2 papers), Pregnancy and preeclampsia studies (1 paper) and Genetic Syndromes and Imprinting (1 paper). Veronica Mason is often cited by papers focused on Kruppel-like factors research (2 papers), Pregnancy and preeclampsia studies (1 paper) and Genetic Syndromes and Imprinting (1 paper). Veronica Mason collaborates with scholars based in United States, Hong Kong and Singapore. Veronica Mason's co-authors include Julian P. T. Higgins, Matt van de Rijn, Kelli Montgomery, Samuel So, Mei‐Sze Chua, James D. Brooks, Lingli Wang, ST Cheung, Gülşah Kaygusuz and Joseph C. Presti and has published in prestigious journals such as Cancer Research, Kidney International and Molecular Biology of the Cell.

In The Last Decade

Veronica Mason

7 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veronica Mason United States 6 355 128 121 114 90 7 570
Ming Y. Tung United States 8 245 0.7× 209 1.6× 51 0.4× 200 1.8× 98 1.1× 9 578
Francine E. Carrick United States 9 308 0.9× 105 0.8× 101 0.8× 134 1.2× 111 1.2× 10 604
Alejandro Rojo‐Sebastián Spain 14 375 1.1× 88 0.7× 75 0.6× 122 1.1× 114 1.3× 18 686
Masayuki Imamura Japan 16 230 0.6× 131 1.0× 289 2.4× 370 3.2× 133 1.5× 24 718
O Nakashima Japan 16 128 0.4× 108 0.8× 221 1.8× 163 1.4× 111 1.2× 30 792
U. Ramp Germany 15 435 1.2× 166 1.3× 51 0.4× 175 1.5× 143 1.6× 35 629
Raymond D. Pastore United States 6 545 1.5× 65 0.5× 61 0.5× 216 1.9× 22 0.2× 11 768
Binhui Ren China 17 568 1.6× 130 1.0× 135 1.1× 151 1.3× 394 4.4× 33 848
Shang-Tian Chuang United States 7 243 0.7× 155 1.2× 79 0.7× 78 0.7× 107 1.2× 8 463
Julie Madden United Kingdom 9 214 0.6× 49 0.4× 33 0.3× 212 1.9× 82 0.9× 14 502

Countries citing papers authored by Veronica Mason

Since Specialization
Citations

This map shows the geographic impact of Veronica Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica Mason more than expected).

Fields of papers citing papers by Veronica Mason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronica Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica Mason. The network helps show where Veronica Mason may publish in the future.

Co-authorship network of co-authors of Veronica Mason

This figure shows the co-authorship network connecting the top 25 collaborators of Veronica Mason. A scholar is included among the top collaborators of Veronica Mason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronica Mason. Veronica Mason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Mason, Veronica, et al.. (2012). 23rd AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: November 12-16, 2011, San Francisco, CA, USA. Drugs of the Future. 37(2). 143–143. 2 indexed citations
2.
Higgins, Julian P. T., Gülşah Kaygusuz, Lingli Wang, et al.. (2007). Placental S100 (S100P) and GATA3: Markers for Transitional Epithelium and Urothelial Carcinoma Discovered by Complementary DNA Microarray. The American Journal of Surgical Pathology. 31(5). 673–680. 170 indexed citations
3.
Fong, Chee Wai, Mei‐Sze Chua, Arthur B. McKie, et al.. (2006). Sprouty 2, an Inhibitor of Mitogen-Activated Protein Kinase Signaling, Is Down-Regulated in Hepatocellular Carcinoma. Cancer Research. 66(4). 2048–2058. 131 indexed citations
4.
Morgan, Terry K., Kelli Montgomery, Veronica Mason, et al.. (2006). Upregulation of histidine decarboxylase expression in superficial cortical nephrons during pregnancy in mice and women. Kidney International. 70(2). 306–314. 14 indexed citations
5.
Chua, Mei‐Sze, ST Cheung, Veronica Mason, et al.. (2006). Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Modern Pathology. 20(1). 76–83. 101 indexed citations
6.
Chen, Xin, Julian P. T. Higgins, ST Cheung, et al.. (2004). Novel endothelial cell markers in hepatocellular carcinoma. Modern Pathology. 17(10). 1198–1210. 70 indexed citations
7.
Higgins, Julian P. T., Lingli Wang, Neeraja Kambham, et al.. (2003). Gene Expression in the Normal Adult Human Kidney Assessed by Complementary DNA Microarray. Molecular Biology of the Cell. 15(2). 649–656. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026